RNS Number : 8852X
Ultrasis PLC
01 July 2008
Ultrasis plc
Ultrasis plc appoints JBP to head up financial,
corporate and consumer communications
Ultrasis plc, the provider of computer-delivered, interactive healthcare products and
associated services, has appointed JBP to lead its
financial PR, investor relations and corporate, trade and consumer communications.
The appointment is made as AIM-listed Ultrasis embarks on a major rollout of its flagship
product designed to treat anxiety and
depression, Beating the Blues, to a wider retail audience.
Beating the Blues is an eight-week, web-based treatment programme for depression based on
Cognitive Behavioural Therapy (CBT) which,
following rigorous assessment was approved by NICE (National Institute for Health and Clinical
Excellence) for use in the NHS in February
2006.
Nigel Brabbins, Chief Executive of Ultrasis plc said: "We want our potential investors,
analysts, employees, customers and the media to
be kept fully abreast of some fast moving developments, which is why JBP has come on board to
lead a wider strategic communications
programme, targeting both existing customers and new, private ones."
JBP was established 24 years ago and has extensive experience developing communications
strategies for companies operating in the
healthcare sector and manages national and international clients.
Financial communications will be handled by the company's investor relations division,
Performance Communications.
Ends
For further information please contact:
Ultrasis plc
Nigel Brabbins, Chief Executive
+44 (0) 20 7566 3900
nbrabbins@ultrasis.com
Geoff Nash,
FinnCap
Nominated Advisor and Joint Broker
+44 (0) 207600 1658
John Webb,
Marshall Securities
Joint Broker
+44 (0) 207 490 3788
Media Enquiries
JBP
Karen White/Sarah Rice
+44 (0) 117 9073400
karen@jbp.co.uk ; sarah@jbp.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAZGGFVFGZGRZM
|